ManuVision Behandling ApS

 

Quicksearch
from your own companies




Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...

Bankruptcy Risk 
2015
N/A
2016
N/A
2017
2017/12
2018
2018/12
2019
2019/12
Bankruptcy risk for industry  5.4% 1.5% 1.5% 1.5% 1.5%  
Bankruptcy risk  0.0% 0.0% 18.3% 33.0% 29.8%  
Credit score (0-100)  0 0 9 1 2  
Credit rating  N/A N/A B C C  
Credit limit (kDKK)  0.0 0.0 0.0 -0.0 0.0  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2015
N/A
2016
N/A
2017
2017/12
2018
2018/12
2019
2019/12

Net sales  0 0 0 0 0  
Gross profit  0.0 0.0 2.0 3,007 584  
EBITDA  0.0 0.0 2.0 -905 136  
EBIT  0.0 0.0 2.0 -933 109  
Pre-tax profit (PTP)  0.0 0.0 0.0 -948.7 719.5  
Net earnings  0.0 0.0 0.0 -739.9 693.8  
Pre-tax profit without non-rec. items  0.0 0.0 0.0 -949 719  

 
See the entire income statement

Balance sheet (kDKK) 
2015
N/A
2016
N/A
2017
2017/12
2018
2018/12
2019
2019/12

Tangible assets total  0.0 0.0 0.0 0.0 0.0  
Shareholders equity total  0.0 0.0 50.0 -690 3.9  
Interest-bearing liabilities  0.0 0.0 10.0 258 0.0  
Balance sheet total (assets)  0.0 0.0 67.0 607 30.7  

Net Debt  0.0 0.0 -57.0 118 -5.7  
 
See the entire balance sheet

Volume 
2015
N/A
2016
N/A
2017
2017/12
2018
2018/12
2019
2019/12

Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  0.0 0.0 2.0 3,007 584  
Gross profit growth  0.0% 0.0% 0.0% 150,244.3% -80.6%  
Employees  0 0 1 0 0  
Employee growth %  0.0% 0.0% 0.0% -100.0% 0.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  0 0 67 607 31  
Balance sheet change%  0.0% 0.0% 0.0% 805.9% -94.9%  
Added value  0.0 0.0 2.0 -932.5 136.3  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  0 0 0 137 -192  

Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  0.0 0.0 1.0 -1.0 1.0  

Profitability 
2015
N/A
2016
N/A
2017
2017/12
2018
2018/12
2019
2019/12
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  0.0% 0.0% 100.0% -31.0% 18.6%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  0.0% 0.0% 3.0% -136.7% 107.9%  
ROI %  0.0% 0.0% 3.3% -586.4% 546.8%  
ROE %  0.0% 0.0% 0.0% -225.3% 227.2%  

Solidity 
2015
N/A
2016
N/A
2017
2017/12
2018
2018/12
2019
2019/12
Equity ratio %  0.0% 0.0% 74.6% -53.2% 12.6%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  0.0% 0.0% -2,850.0% -13.1% -4.2%  
Gearing %  0.0% 0.0% 20.0% -37.4% 0.0%  
Net interest  0 0 0 0 0  
Financing costs %  0.0% 0.0% 40.0% 12.0% -2.6%  

Liquidity 
2015
N/A
2016
N/A
2017
2017/12
2018
2018/12
2019
2019/12
Quick Ratio  0.0 0.0 3.9 0.3 1.1  
Current Ratio  0.0 0.0 3.9 0.3 1.1  
Cash and cash equivalent  0.0 0.0 67.0 139.8 5.7  

Capital use efficiency 
2015
N/A
2016
N/A
2017
2017/12
2018
2018/12
2019
2019/12
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  0.0 0.0 50.0 -854.5 3.9  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2015
N/A
2016
N/A
2017
2017/12
2018
2018/12
2019
2019/12
Net sales / employee  0 0 0 0 0  
Added value / employee  0 0 2 0 0  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  0 0 2 0 0  
EBIT / employee  0 0 2 0 0  
Net earnings / employee  0 0 0 0 0